<div id="readability-page-1"><div>Klinger Shannon Thyme Officer of Moderna Inc [MRNA] filed a Form 4 on December 2, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:<div><table><tbody><tr><th>Date</th><th>Transaction</th><th>Shares</th><th>Price</th><th>Value</th></tr><tr><td>12/1/25</td><td>Exercise</td><td>233</td><td>$0.00</td><td>N/A</td></tr><tr><td>12/1/25</td><td>Surrender(1)</td><td>113</td><td>$25.98</td><td>$2,936</td></tr></tbody></table></div>Ending Holdings: 28,858 - Direct<ul><li>(1)</li><li>Surrender of shares back to company to pay option exercise cost and/or resulting tax liability.</li></ul>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data. </div></div>

MRNA

Klinger Shannon Thyme, an officer of Moderna Inc, filed a Form 4 with the SEC on December 2, 2025, disclosing changes in ownership. On December 1, 2025, Klinger exercised 233 shares at $0.00 and surrendered 113 shares at $25.98 to cover option exercise costs and/or tax liabilities. The ending holdings are 28,858 shares directly. The Washington Service provides insider trading analysis and data services.

Officer Klinger Acquires 120 Of Moderna Inc [MRNA]